BioCrossroads, the statewide life sciences initiative, has released a profile of a dozen "critical" players in the development of the sector. The white paper, authored by Indiana Fiscal Policy Institute President John Ketzenberger, features leaders the organization says "mind the money, the molecules and the management" of the $62 billion industry.
The paper focuses on the contributors’ leadership, innovations and economics that have built the entrepreneurial community in the state. BioCrossroads Chief Executive Officer David Johnson says "Indiana has long benefited from a tradition of talented leaders who have turned innovations into thriving enterprises – such as the well-known examples of Colonel Eli Lilly and Eli and Lilly and Company; Bill Cook and Cook Group; Dane Miller and Biomet; and Bill Eason, whose discoveries in his garage led ultimately to Roche Diagnostics."
Those featured are:
- Michael Arpey, the managing director and head of investor relations for the Carlyle Group;
- Joe Muldoon, chief executive officer, FAST BioMedical;
- Bruce Molitoris, founder and medical director, FAST BioMedical, IU Distinguished Professor of Medicine and Integrated and Cellular Physiology, Director of Indiana Center for Biological Microscopy;
- N. Clay Robbins, the chairman, president and chief executive officer of Lilly Endowment Inc.;
- Claire Fiddian-Green, president and chief executive officer of the Richard M. Fairbanks Foundation;
- Laura Lyons, vice president, compliance and respiratory care, SonarMed;
- Kristin Sherman, Kristin Sherman, CFO VMS BioMarketing, formerly CFO Marcadia and Calibrium;
- Mark Kelley, founder Apex, Betty and Earl Herr Professor in Pediatric Oncology Research and Professor, Departments of Pediatrics, Biochemistry & Molecular Biology and Pharmacology & Toxicology, Associate Director, Herman B Wells Center for Pediatric Research, Associate Director of Basic Science Research, Indiana University Simon Cancer Center, Director, Program in Pediatric Molecular Oncology & Experimental Therapeutics, Co-Director, Center for Pancreatic Cancer Research;
- Anantha Shekhar, founder, Anagin, Director, Indiana Clinical and Translational Sciences Institute, Associate VP for Research, Indiana University, Executive Associate Dean for Research Affairs, August M. Watanabe Professor of Medical Research, Professor of Psychiatry, Pharmacology and Neurobiology, Indiana University School of Medicine;
- Darren Carroll, senior vice president of corporate business development, Eli Lilly and Company;
- Derek Small, chief executive officer, Assembly Biosciences;
- Richard DiMarchi, Standiford H. Cox Professor of Chemistry and the Linda & Jack Gill Chair in Biomolecular Sciences at Indiana University. Co-founder of Ambrx, Inc., Marcadia Biotech, Calibrium and MB2.
You can connect to the full white paper titled "Powering Indiana’s Life Sciences Community: Profiles of Money, Molecules and Management" by clicking here.